Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
The British Journal of Ophthalmology
|
September 8, 2011
Authors’ response
Radouil Tzekov, Carol Bigelow, Christine Clemson, et al.
Current Medical Research and Opinion
|
November 24, 2018
The humanistic burden of postpartum depression: a systematic literature review
Tiffany A Moore Simas, Ming-Yi Huang, Cody Patton, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2025
Odevixibat for Episodic Intrahepatic Cholestasis due to Biallelic Mutations in ATP8B1: A Case Series
Angelo Di Giorgio, Hans Blokzijl, Emmanuel Gonzalès, et al.
Lancet (London, England)
|
September 5, 2018
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Samantha Meltzer-Brody, Helen Colquhoun, Robert Riesenberg, et al.
The Lancet. Gastroenterology & Hepatology
|
April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
The British Journal of Ophthalmology
|
September 8, 2011
Authors’ response
Radouil Tzekov, Carol Bigelow, Christine Clemson, et al.
Current Medical Research and Opinion
|
November 24, 2018
The humanistic burden of postpartum depression: a systematic literature review
Tiffany A Moore Simas, Ming-Yi Huang, Cody Patton, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 7, 2025
Odevixibat for Episodic Intrahepatic Cholestasis due to Biallelic Mutations in ATP8B1: A Case Series
Angelo Di Giorgio, Hans Blokzijl, Emmanuel Gonzalès, et al.
Lancet (London, England)
|
September 5, 2018
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Samantha Meltzer-Brody, Helen Colquhoun, Robert Riesenberg, et al.
The Lancet. Gastroenterology & Hepatology
|
April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
Page
of 1